• Therapeutic expertise driving product potential

  • Deep therapeutic knowledge combined with clinical development experience drives more effective and efficient pathways to commercialization.

    • Helping you meet regulatory requirements in each jurisdiction for study execution and market entry
    • Ensuring your data are scientifically meaningful to the clinical, regulatory, payer and patient communities
    • Targeting your product messaging to each market and stakeholder, from payers in Japan to patients in Africa

  • Our Perspectives

    slider image

    Tomorrow’s Path to Improved Early-Phase Oncology Drug Development

    Maximizing quality and efficiency of go/no-go decisions in early-phase studies. Read white paper

    slider image

    Harnessing the Power of the Digital Patient

    This white paper discusses how biopharmaceutical companies can harness the power of the digital patient when it engages them in the appropriate manner. Read white paper

    slider image

    New Voices, New Opportunities

    Navigate the increasingly tricky waters of commercializing products by adjusting to the needs of a new set of stakeholders. Read white paper

    slider image

    Precision Planning

    Proactive planning yields high-quality data. Robust data management kept this post-marketing diabetes study on track and on time. Read case study

    slider image

    Expediting Diagnosis

    Nurse Educator Initiative boosts awareness and screenings. Read case study

  •  
     

    Video Spotlights 

  • Therapeutic specialists who make the most of your opportunities

    Quintiles
    At any stage in your product’s lifecycle, we help you navigate the unique challenges of your market.

    Global health threats like malaria, H1N1 and avian flu require a preventive approach. Read more

    From biomarkers to market access, Quintiles has more oncology experience than any other CRO. Learn more

    With new scrutiny on cardiac safety, how can you streamline diabetes trials? Find out

  • Our Perspectives

    Harnessing the Power of the Digital Patient White Paper
    Read more

    Tomorrow’s Path to Improved Early-Phase Oncology Drug Development
    Read more

    Strategic Portfolio Management & New Influencers in R&D Decision-Making
    Read more

    Featured News

    Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research
    Read more

    Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock
    Read more

    Quintiles Announces Pricing of Initial Public Offering
    Read more